Valuation (31%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -14.18 | N/A |
PEG Ratio (TTM) | 0.78 | N/A |
P/S Ratio (TTM) | 2.56 | N/A |
P/B Ratio (TTM) | 1.64 | N/A |
P/FCF Ratio (TTM) | -10.08 | N/A |
Price to 5YR AVG Earnings Ratio | -3.37 | N/A |
Price to 5YR AVG FCF Ratio | -5.47 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -9.16% | N/A |
ROE (TTM) | -10.78% | N/A |
Net Profit Margin (TTM) | -17.95% | N/A |
ROIC 5YR AVG | -71.93% | N/A |
Growth (12%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -9.54% | -0.47% | 5.72% |
Revenue | 1.57% | 10.12% | -4.92% |
Net Income | -9.12% | -14.70% | -0.21% |
Cash Flow | -536.39% | -38.92% | -18.30% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 4.02 | N/A |
Quick Ratio (TTM) | 3.91 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -437.14 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.03 | N/A |
Shares Outstanding Growth 5YR AVG | 9.18% | N/A |